Clinical Research Directory
Browse clinical research sites, groups, and studies.
Interleukin 6-guided Antibiotic Prescriptions in AECOPD Inpatients
Sponsor: Ningbo No. 1 Hospital
Summary
In this multicenter, prospective, randomized controlled study, we aimed to figure out, compared with the global chronic obstructive pulmonary disease initiative (GOLD) guideline -guided antibiotic therapy, whether Interleukin 6 (IL6)-guided antibiotic therapy for acute exacerbation of chronic obstructive pulmonary disease (AECOPD) can lead to a reduction in the use of antibiotics without increasing the rate of treatment failure.
Official title: Interleukin 6-guided Antibiotic Prescriptions in AECOPD Inpatients: a Multicenter Randomized Controlled Trial
Key Details
Gender
All
Age Range
40 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
440
Start Date
2024-09-20
Completion Date
2026-08-31
Last Updated
2024-09-25
Healthy Volunteers
No
Interventions
Interleukin 6-guided antibiotic therapy
In Interleukin-6 group, antibiotic prescription decisions will made according to the results of IL-6.
GOLD-guided antibiotic therapy
In guideline group, antibiotic prescription decisions will made according to the recommendations of GOLD guideline.